Enteropathic arthritis
Peripheral type 1 and type 2 arthritis and axial disease in IBD, which forms track bowel activity, the arthralgia and drug reactions that mimic it, and choosing one drug for gut and joints.
Tier 1Condition
Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made
At a glance
- Arthritis is the commonest extraintestinal manifestation of IBD. Peripheral arthritis affects about 10 to 20% of people with Crohn disease or UC; axial disease (sacroiliitis on imaging) is found in up to a quarter, though symptomatic AS affects only about 3 to 10%.
- More common in Crohn disease, especially colonic, and when other extraintestinal features are present.
- Type 1 peripheral arthritis tracks bowel activity. Type 2 and axial disease don't. That decides whether treating the gut will fix the joints.
Loading the rest of the note…
Finished reading?
Sources
- Therapeutic Guidelines: Rheumatology (spondyloarthritis) and Gastrointestinal (inflammatory bowel disease)AU/NZTherapeutic Guidelines Limited (eTG complete), current online version, accessed November 2026
- Services Australia: PBS biological medicines for ulcerative colitis and for adult Crohn disease (lists of subsidised agents)AU/NZServices Australia, accessed 13 November 2026
- Gordon H et al. ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease. J Crohns Colitis 2024;18:1-37European Crohn's and Colitis Organisation, 2024
- Orchard TR et al. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998;42:387-91Gut, 1998
- Ramiro S et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis 2023;82:19-34ASAS and EULAR, 2022 update
- Last updated
- 14 November 2026
What changed
- 14 November 2026 Personal emails, About story and Australian-style copy